drugset / Trial / NCT04799782

Role of Mirtazapine in Ameliorating Sleep Disordered Breathing

NCT04799782

Phase 2 Completed 18 enrolled Wayne State University
RandomizedCrossoverSingle-blindOther

Summary

The purpose of this study is to look at the effect of using Mirtazapine to target a specific pathway in the body, that relies on a natural chemical the body produces called 'serotonin', in patients with spinal cord injury (SCI) and non-injured persons during sleep. During this part of the study participants will be asked to take Mirtazapine (15mg per day) and a placebo in a random fashion, each for a one week period (drug period) of time followed by one week without drugs (washout period). The drugs will not be taken all at the same time, but each will be taken separately for one weeks followed by a night study to look at the effect the Mirtazapine/placebo pill has on the way the body responds during sleep.

Timeline

Start
2017-01
Primary completion
2019-05-18
Completion
2019-05-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mirtazapine Other / unclassified 15 mg